Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Anti-Basonuclin Antibody

Product Specifications

CAS Number

9007-83-4

Gene Name

[BNC1]

NCBI Gene ID

646

Reactivity

Human, Mouse, Rat

Storage Conditions

Shipped at 4 °C. Upon delivery aliquot and store at -20 °C for one year. Avoid freeze/thaw cycles.

Specificity

Recognizes endogenous levels of Basonuclin protein.

Other Gene Names

[BNC1; BNC1; BNC; BSN1; HsT19447; BNC]

Short Name

[Basonuclin]

Other Product Names

[zinc finger protein basonuclin-1 isoform b; Zinc finger protein basonuclin-1; zinc finger protein basonuclin-1; basonuclin 1]

NCBI GI Number

667714407

NCBI Accession Number

NP_001288135.1

NCBI GB Accession Number

NM_001301206.1

Uniprot Accession Number

Q01954

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Lentiviral human C10orf90 shRNA (UAS) - Lentiviral human C10orf90 shRNA (UAS, RFP) plasmid
GTR15124993 1 Vial

Lentiviral human C10orf90 shRNA (UAS) - Lentiviral human C10orf90 shRNA (UAS, RFP) plasmid

Ask
View Details
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target)
MBS4380958-01 0.02 mg (With BSA & Azide at 0.2mg/mL)

PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target)

Ask
View Details
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target)
MBS4380958-02 0.1 mg (With BSA & Azide at 0.2mg/mL)

PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target)

Ask
View Details
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target)
MBS4380958-03 0.1 mg (Without BSA & Azide at 1mg/mL)

PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target)

Ask
View Details
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target)
MBS4380958-04 5x 0.1 mg (With BSA & Azide at 0.2mg/mL)

PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target)

Ask
View Details
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target)
MBS4380958-05 5x 0.1 mg (Without BSA & Azide at 1mg/mL)

PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target)

Ask
View Details